Markers of renal function and acute kidney injury in acute heart failure: definitions and impact on outcomes of the cardiorenal syndrome. (1/63)

Renal function and mortality following cardiac resynchronization therapy. (2/63)

Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome. (3/63)

Clinical outcome of renal tubular damage in chronic heart failure. (4/63)

Higher hemoglobin level is associated with subtle declines in renal function and presence of cardiorenal risk factors in early CKD stages. (5/63)

Mineralocorticoid receptor antagonism: therapeutic potential in acute heart failure syndromes. (6/63)

Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome. (7/63)

New roles for renin and prorenin in heart failure and cardiorenal crosstalk. (8/63)

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8